---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-091433"
form_type: "8-K"
ticker: "XWEL"
cik: "0001410428"
company_name: "XWELL, Inc."
filed_at: "2023-08-14T23:59:59+00:00"
generated_at: "2026-06-11T10:36:03.969756+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# XWELL Q2 2023 revenue down 40% YoY; net loss improves to $5.7M; CDC renews $15.9M biosurveillance contract

## Summary
- Revenue $8.2M vs $13.6M in Q2 2022; XpresSpa revenue up 59% YoY.
- Net loss attributable to common shareholders $5.7M, improved from $7.9M loss.
- CDC renews biosurveillance program with contract value ~$15.9M; all XpresCheck locations closed.
- Appointed Suzanne Scrabis as CFO effective July 10, 2023.
- Cash and marketable securities $31.9M; no long-term debt.

## SEC filing metadata
- accession: 0001104659-23-091433
- form_type: 8-K
- ticker: XWEL
- cik: 0001410428
- company_name: XWELL, Inc.
- filed_at: 2023-08-14T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1410428/000110465923091433/0001104659-23-091433-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1410428/000110465923091433/tm2323722d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-091433
- JSON: https://secwatch.observer/filing/0001104659-23-091433.json
- Plain text: https://secwatch.observer/filing/0001104659-23-091433.txt

## Key facts
- Earnings Releases
  XWELL, Inc. reported financial results for second quarter ended June 30, 2023.
  - Period: second quarter ended June 30, 2023
  - Result: reported results
  source text: XWELL, Inc., dated August 14, 2023, announcing certain operating results for the fiscal quarter ended June 30, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1410428/000110465923091433/0001104659-23-091433-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.